British brain imaging study to focus on LSD

Evan Godt | | Health Imaging | Neuroimaging

Scientists at Imperial College London are trying to complete a brain imaging study to demystify the effects of the psychedelic drug LSD, and they are turning to crowdfunding to support the project.

David Nutt, DM, psychiatrist and professor of psychopharmacology, and colleagues are looking for an additional 25,000 pounds ($38,000) to complete their work, according to a Reuters report. The study would produce the first images of a brain on LSD and could increase understanding of how the drug could help treat afflictions such as alcoholism, depression and anxiety.

You can watch the researcher’s appeal for funding in this video, and learn more about the project from the Reuters report at the link below:

Crowdfunding psychedelics: LSD brain-imaging study seeks funds

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

More than 1/3 of old strokes are incidentally detected on head CT
AI-based ARIA detection software could bring 'renewed hope' for people undergoing Alzheimer's treatment
Dual energy CT parameters help determine the type of clot behind strokes
Socioeconomic disadvantage during childhood linked to altered brain structure later in life, MRIs show
The Mediterranean diet may slow brain aging, MRI study shows
Researchers receive grant worth millions to develop portable PET scanner

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.